94 related articles for article (PubMed ID: 18514560)
1. Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell line.
Ristić-Fira AM; Petrović IM; Korićanac LB; Valastro LM; Privitera G; Cuttone G
Phys Med; 2008 Dec; 24(4):187-95. PubMed ID: 18514560
[TBL] [Abstract][Full Text] [Related]
2. Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beam.
Petrović I; Ristić-Fira A; Todorović D; Valastro L; Cirrone P; Cuttone G
Int J Radiat Biol; 2006 Apr; 82(4):251-65. PubMed ID: 16690593
[TBL] [Abstract][Full Text] [Related]
3. Viability of a human melanoma cell after single and combined treatment with fotemustine, dacarbazine, and proton irradiation.
Petrović IM; Korićanac LB; Todorović DV; Ristić-Fira AM; Valastro LM; Privitera G; Cuttone G
Ann N Y Acad Sci; 2007 Jan; 1095():154-64. PubMed ID: 17404028
[TBL] [Abstract][Full Text] [Related]
4. Response of a human melanoma cell line to low and high ionizing radiation.
Ristic-Fira AM; Todorovic DV; Koricanac LB; Petrovic IM; Valastro LM; Cirrone PG; Raffaele L; Cuttone G
Ann N Y Acad Sci; 2007 Jan; 1095():165-74. PubMed ID: 17404029
[TBL] [Abstract][Full Text] [Related]
5. Proton inactivation of melanoma cells enhanced by fotemustine.
Ristić-Fira A; Korićanac L; Žakula J; Keta O; Iannolo G; Cuttone G; Petrović I
Radiat Prot Dosimetry; 2011 Feb; 143(2-4):503-7. PubMed ID: 21183545
[TBL] [Abstract][Full Text] [Related]
6. Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak.
Petrović I; Ristić-Fira A; Todorović D; Korićanac L; Valastro L; Cirrone P; Cuttone G
Int J Radiat Biol; 2010 Sep; 86(9):742-51. PubMed ID: 20597839
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of HTB63 human melanoma cells by irradiation with protons and gamma rays.
Ristic-Fira A; Petrovic I; Todorovic D; Koricanac L; Vujèic M; Demajo M; Sabini G; Cirrone P; Cuttone G
Oncol Rep; 2004 Dec; 12(6):1323-8. PubMed ID: 15547758
[TBL] [Abstract][Full Text] [Related]
8. Early effects of gamma rays and protons on human melanoma cell viability and morphology.
Todorović D; Petrović I; Todorović M; Cuttone G; Ristić-Fira A
J Microsc; 2008 Dec; 232(3):517-21. PubMed ID: 19094032
[TBL] [Abstract][Full Text] [Related]
9. Effects of fotemustine or dacarbasine on a melanoma cell line pretreated with therapeutic proton irradiation.
Ristić-Fira AM; Korićanac LB; Zakula JJ; Valastro LM; Iannolo G; Privitera G; Cuttone G; Petrović IM
J Exp Clin Cancer Res; 2009 Apr; 28(1):50. PubMed ID: 19358719
[TBL] [Abstract][Full Text] [Related]
10. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc.
Kriehuber R; Kadenbach K; Schultz F; Weiss DG
Int J Radiat Biol; 2004; 80(11-12):875-80. PubMed ID: 15764396
[TBL] [Abstract][Full Text] [Related]
11. Response of human HTB140 melanoma cells to conventional radiation and hadrons.
Ristić-Fira A; Todorović D; Zakula J; Keta O; Cirrone P; Cuttone G; Petrović I
Physiol Res; 2011; 60(Suppl 1):S129-35. PubMed ID: 21777021
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and clonogenic survival in three tumour cell lines exposed to gamma rays or chemical genotoxic agents.
Kumala S; Niemiec P; Wideł M; Hancock R; Rzeszowska-Wolny J
Cell Mol Biol Lett; 2003; 8(3):655-65. PubMed ID: 12949606
[TBL] [Abstract][Full Text] [Related]
13. Relative biological effectiveness of 6 MeV neutrons with respect to cell inactivation and disturbances of the G1 phase.
Zölzer F; Streffer C
Radiat Res; 2008 Feb; 169(2):207-13. PubMed ID: 18220459
[TBL] [Abstract][Full Text] [Related]
14. Similar extent of apoptosis induction at doses of X-rays and neutrons isoeffective for cell inactivation.
Oya N; Zölzer F; Werner F; Streffer C
Strahlenther Onkol; 2008 May; 184(5):270-5. PubMed ID: 18427758
[TBL] [Abstract][Full Text] [Related]
15. B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment.
Olszewska-Słonina DM; Styczyńisk J; Drewa TA; Olszewski KJ; Czajkowski R
Acta Pol Pharm; 2005; 62(6):473-83. PubMed ID: 16583988
[TBL] [Abstract][Full Text] [Related]
16. Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay.
Wouters BG; Lam GK; Oelfke U; Gardey K; Durand RE; Skarsgard LD
Radiat Res; 1996 Aug; 146(2):159-70. PubMed ID: 8693066
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumour activity of fotemustine and protons in combination with bevacizumab.
Korićanac LB; Zakula JJ; Petrović IM; Valastro LM; Cirrone GA; Cuttone G; Ristić-Fira AM
Chemotherapy; 2010; 56(3):214-22. PubMed ID: 20551638
[TBL] [Abstract][Full Text] [Related]
18. Effects of cisplatin and gamma-irradiation on cell survival, the induction of chromosomal aberrations and apoptosis in SW-1573 cells.
Bergs JW; Franken NA; ten Cate R; van Bree C; Haveman J
Mutat Res; 2006 Feb; 594(1-2):148-54. PubMed ID: 16202432
[TBL] [Abstract][Full Text] [Related]
19. Effect of dose rate on the radiation-induced bystander response.
Gow MD; Seymour CB; Byun SH; Mothersill CE
Phys Med Biol; 2008 Jan; 53(1):119-32. PubMed ID: 18182691
[TBL] [Abstract][Full Text] [Related]
20. Relative biological effectiveness of fast neutrons in a multiorgan assay for apoptosis in mouse.
Lee HJ; Kim JS; Moon C; Kim JC; Jo SK; Kim SH
Environ Toxicol; 2008 Apr; 23(2):233-9. PubMed ID: 18214905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
